Karyopharm Therapeutics
KPTI
#9487
Rank
A$80.8 M
Marketcap
$9.43
Share price
8.01%
Change (1 day)
460.73%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.98

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.05. In 2022 the company made an earnings per share (EPS) of -$3.15 a decrease over its 2021 EPS that were of -$2.58.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.98-37.11%
2022-$3.1522.29%
2021-$2.58-39.19%
2020-$4.24-15.48%
2019-$5.023.19%
2018-$4.8611.79%
2017-$4.35-4.44%
2016-$4.55-11.75%
2015-$5.1637.76%
2014-$3.74-74.5%
2013-$14.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.83-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.17-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.62-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.44-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA